Chronic Subdural Hematoma in Elderly Patients: Is This Disease Benign?

As the world population becomes progressively older, the overall incidence of chronic subdural hematoma (CSDH) is increasing. Peak age of onset for CSDH has also increased, and recently the 80-year-old level has a peak. Many patients with CSDH have had prior treatment with anticoagulants and antipla...

Full description

Saved in:
Bibliographic Details
Published inNeurologia medico-chirurgica Vol. 57; no. 8; pp. 402 - 409
Main Authors HIRAI, Satoshi, TOI, Hiroyuki, UNO, Masaaki
Format Journal Article
LanguageEnglish
Published Japan The Japan Neurosurgical Society 2017
Japan Science and Technology Agency
Subjects
Online AccessGet full text

Cover

Loading…
Abstract As the world population becomes progressively older, the overall incidence of chronic subdural hematoma (CSDH) is increasing. Peak age of onset for CSDH has also increased, and recently the 80-year-old level has a peak. Many patients with CSDH have had prior treatment with anticoagulants and antiplatelet drugs, which have an accompanying risk of CSDH. In elderly patients with CSDH, symptoms of cognitive change (memory disturbance, urinary incontinence, and decreased activity) and disturbance of consciousness at admission were more frequent compared to younger patients with CSDH. The literature actually offers conflicting advice regarding CSDH treatment; however, burr hole surgery with drainage under local anesthesia is the most common surgical procedure, even in elderly patients. The recurrence rate of CSDH has not decreased over recent decades, and it has ranged from 0.36–33.3%. Outcomes in patients over 75 years old was significantly worse than for those younger than 75. Moreover, long-term outcomes for elderly patients with CSDH are poor. CSDH in the elderly is no longer a benign disease. In the future, it will be important for us to understand the mechanisms of onset and recurrence of CSDH and to develop more effective medical treatments and noninvasive surgical techniques for elderly patients.
AbstractList As the world population becomes progressively older, the overall incidence of chronic subdural hematoma (CSDH) is increasing. Peak age of onset for CSDH has also increased, and recently the 80-year-old level has a peak. Many patients with CSDH have had prior treatment with anticoagulants and antiplatelet drugs, which have an accompanying risk of CSDH. In elderly patients with CSDH, symptoms of cognitive change (memory disturbance, urinary incontinence, and decreased activity) and disturbance of consciousness at admission were more frequent compared to younger patients with CSDH. The literature actually offers conflicting advice regarding CSDH treatment; however, burr hole surgery with drainage under local anesthesia is the most common surgical procedure, even in elderly patients. The recurrence rate of CSDH has not decreased over recent decades, and it has ranged from 0.36–33.3%. Outcomes in patients over 75 years old was significantly worse than for those younger than 75. Moreover, long-term outcomes for elderly patients with CSDH are poor. CSDH in the elderly is no longer a benign disease. In the future, it will be important for us to understand the mechanisms of onset and recurrence of CSDH and to develop more effective medical treatments and noninvasive surgical techniques for elderly patients.
Author TOI, Hiroyuki
UNO, Masaaki
HIRAI, Satoshi
Author_xml – sequence: 1
  fullname: HIRAI, Satoshi
  organization: Department of Neurosurgery, Kawasaki Medical School
– sequence: 1
  fullname: TOI, Hiroyuki
  organization: Department of Neurosurgery, Kawasaki Medical School
– sequence: 1
  fullname: UNO, Masaaki
  organization: Department of Neurosurgery, Kawasaki Medical School
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28652561$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtv1DAUhS1U1E4fe1bIEusMfsSPsACVoUMrVQKp7dpynJsZV4lT7ASp_x6n044KCza-C5_v3KNzj9FBGAIg9I6SJaNKfgy9W0a7ZITKgnCu3qAF5WVVaMKqA7QgpSKFpkQcobOUfE0IK3XJtTpER0xLwYSkC7RebeMQvMM3U91M0Xb4Eno7Dr3FPuCLroHYPeKfdvQQxvQJXyV8u_UJf_MJbAL8FYLfhC-n6G1ruwRnz_ME3a0vbleXxfWP71er8-vCCaXGwuraOcZaoWqnrJV1w9sc1wGrGy0aWrGKl1qSlmoFgpdEAFROipIrrmnN-Qn6vPN9mOoeGpdD5czmIfrexkczWG_-_gl-azbDbyOElLKqssGHZ4M4_JogjeZ-mGLImU0uUhBeKaay6v3rNXv_l96yQO4ELg4pRWiN82MuaZi3-s5QYuYbmXwjE-1sLc18owySf8AX7_8g6x1yn0a7gT1g4-hdB0-AUEbPz2twL3BbGw0E_gcZx62p
CitedBy_id crossref_primary_10_1186_s41016_022_00287_z
crossref_primary_10_32587_jnic_2023_00584
crossref_primary_10_1016_j_wneu_2022_11_097
crossref_primary_10_1089_neu_2018_5821
crossref_primary_10_1016_j_wneu_2017_07_057
crossref_primary_10_1016_j_inat_2020_100736
crossref_primary_10_1080_02688697_2024_2333399
crossref_primary_10_1016_j_clineuro_2024_108323
crossref_primary_10_1016_j_inat_2021_101386
crossref_primary_10_1055_a_1698_6212
crossref_primary_10_1186_s41016_021_00263_z
crossref_primary_10_25259_SNI_1086_2022
crossref_primary_10_1001_jamaneurol_2022_4133
crossref_primary_10_1136_neurintsurg_2020_016552
crossref_primary_10_1016_j_wneu_2024_09_002
crossref_primary_10_1016_j_wneu_2024_09_046
crossref_primary_10_1136_jnis_2023_020132
crossref_primary_10_13004_kjnt_2024_20_e18
crossref_primary_10_3389_fphys_2020_01009
crossref_primary_10_1007_s00234_024_03490_0
crossref_primary_10_25259_SNI_1003_2024
crossref_primary_10_1016_j_jocn_2021_01_039
crossref_primary_10_7759_cureus_18868
crossref_primary_10_3390_jal5020011
crossref_primary_10_1007_s12630_024_02703_7
crossref_primary_10_3389_fneur_2024_1453629
crossref_primary_10_1016_j_ctcp_2021_101307
crossref_primary_10_1016_j_wneu_2019_02_121
crossref_primary_10_1016_j_wneu_2024_123606
crossref_primary_10_1016_j_wneu_2019_10_023
crossref_primary_10_1007_s00701_023_05543_4
crossref_primary_10_1080_02699052_2024_2304860
crossref_primary_10_1007_s12031_021_01910_x
crossref_primary_10_3340_jkns_2021_0138
crossref_primary_10_1016_j_wneu_2021_04_052
crossref_primary_10_7759_cureus_16231
crossref_primary_10_3171_2020_7_FOCUS20237
crossref_primary_10_1177_1536012120914773
crossref_primary_10_3389_fneur_2020_00550
crossref_primary_10_1097_TGR_0000000000000224
crossref_primary_10_25259_SNI_950_2021
crossref_primary_10_1007_s11357_022_00570_y
crossref_primary_10_4103_bc_bc_73_20
crossref_primary_10_3389_fneur_2023_1218334
crossref_primary_10_1016_j_clineuro_2024_108186
crossref_primary_10_25259_SNI_911_2021
crossref_primary_10_3390_jcm11051178
crossref_primary_10_7759_cureus_18361
crossref_primary_10_1007_s10143_021_01586_2
crossref_primary_10_3171_2020_7_FOCUS20518
crossref_primary_10_1016_j_jocn_2021_05_036
crossref_primary_10_1016_j_wneu_2021_02_036
crossref_primary_10_2176_jns_nmc_2022_0207
crossref_primary_10_25259_SNI_97_2021
crossref_primary_10_1007_s00701_020_04569_2
crossref_primary_10_1089_neu_2023_0413
crossref_primary_10_2176_jns_nmc_2022_0327
crossref_primary_10_4103_aian_aian_818_23
crossref_primary_10_1007_s13760_022_02154_1
crossref_primary_10_1016_j_wneu_2019_08_003
crossref_primary_10_1016_j_wneu_2019_05_063
crossref_primary_10_1016_j_wneu_2020_10_035
crossref_primary_10_1038_s41598_022_10992_5
crossref_primary_10_1016_j_jocn_2023_07_001
crossref_primary_10_1186_s41984_023_00251_8
crossref_primary_10_1136_jnis_2024_021686
crossref_primary_10_1111_ijcp_15014
crossref_primary_10_1136_jnis_2025_023109
crossref_primary_10_1055_s_0043_1771372
crossref_primary_10_1136_jnis_2024_022932
crossref_primary_10_1016_j_wneu_2019_07_168
crossref_primary_10_1055_s_0041_1740942
crossref_primary_10_1093_neuros_nyy443
crossref_primary_10_1016_j_jocn_2021_10_037
crossref_primary_10_1136_jnis_2022_019105
crossref_primary_10_1371_journal_pone_0288872
crossref_primary_10_1177_15910199231225832
crossref_primary_10_3390_diagnostics14222494
crossref_primary_10_1016_j_wneu_2025_123843
crossref_primary_10_1186_s41984_024_00332_2
crossref_primary_10_3390_brainsci15010058
crossref_primary_10_1136_neurintsurg_2019_014730
crossref_primary_10_3340_jkns_2018_0011
crossref_primary_10_1016_j_clineuro_2019_05_012
crossref_primary_10_1016_j_wneu_2021_03_002
crossref_primary_10_1227_neu_0000000000002076
crossref_primary_10_2176_nmc_oa_2020_0287
crossref_primary_10_1111_ane_13518
crossref_primary_10_1016_j_jocn_2019_06_026
crossref_primary_10_1016_j_wneu_2019_11_080
crossref_primary_10_1177_15910199231217144
crossref_primary_10_25259_SNI_676_2021
Cites_doi 10.1016/j.jocn.2008.06.023
10.1007/s00701-016-2902-5
10.3171/2016.1.JNS152655
10.2176/nmc.oa.2013-0390
10.1227/NEU.0000000000001393
10.1007/s00701-012-1334-0
10.1016/j.wneu.2015.10.025
10.2176/nmc.oa.2015-0256
10.2739/kurumemedj.41.81
10.1227/01.NEU.0000298908.94129.67
10.2176/nmc.32.207
10.2176/nmc.12.71
10.3171/2013.3.JNS122162
10.2176/nmc.41.371
10.1007/s10143-004-0337-6
10.1258/jrsm.95.6.290
10.1179/1743132813Y.0000000163
10.1016/j.jocn.2015.03.064
10.3171/2016.9.JNS16623
10.1007/s13670-016-0166-9
10.1007/s00701-015-2625-z
10.2215/CJN.03781106
10.1016/j.wneu.2015.08.044
10.3171/jns.2000.93.4.0686
10.1097/TA.0b013e3181a5f31c
10.1136/jnnp.74.7.937
10.1007/s10143-011-0349-y
10.2215/CJN.01650506
10.1007/s00701-012-1434-x
10.1093/ageing/28.6.519
10.1111/j.1468-1331.2012.03768.x
10.3171/2015.5.JNS1567
10.4103/2152-7806.116679
10.1371/journal.pone.0103703
10.1016/j.ijsu.2013.05.007
10.1016/j.wneu.2012.06.026
10.2176/nmc.21.1153
10.1179/1743132815Y.0000000083
10.3171/2015.2.JNS141889
10.7326/0003-4819-82-5-650
10.1080/02688690802195381
10.1016/j.jocn.2016.05.026
10.3340/jkns.2011.50.6.512
10.3171/2014.5.JNS132715
10.1371/journal.pone.0068732
10.13004/kjnt.2014.10.2.49
10.2739/kurumemedj.58.35
10.3171/2010.8.JNS10298
10.1007/s12245-010-0230-8
10.1016/j.jocn.2004.12.013
10.3171/2014.9.JNS141550
10.1016/j.wneu.2015.09.035
10.1227/01.NEU.0000335782.60059.17
10.1093/ndt/gfq013
10.1007/s101430100182
10.1016/j.clineuro.2004.09.015
10.1007/BF01405457
10.1016/0090-3019(95)00249-9
ContentType Journal Article
Copyright 2017 by The Japan Neurosurgical Society
Copyright Japan Science and Technology Agency 2017
2017 The Japan Neurosurgical Society 2017
Copyright_xml – notice: 2017 by The Japan Neurosurgical Society
– notice: Copyright Japan Science and Technology Agency 2017
– notice: 2017 The Japan Neurosurgical Society 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
K9.
5PM
DOI 10.2176/nmc.ra.2016-0337
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
ProQuest Health & Medical Complete (Alumni)
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Neurosciences Abstracts
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)


MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1349-8029
EndPage 409
ExternalDocumentID PMC5566699
28652561
10_2176_nmc_ra_2016_0337
article_nmc_57_8_57_ra_2016_0337_article_char_en
Genre Journal Article
Comparative Study
Review
GroupedDBID ---
.55
.GJ
123
29N
2WC
3O-
53G
7.U
ACPRK
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BKOMP
CS3
DIK
DU5
E3Z
F5P
GROUPED_DOAJ
GX1
HYE
JMI
JSF
JSH
KQ8
MOJWN
OK1
OVT
P6G
PGMZT
RJT
RNS
RPM
RZJ
TKC
TR2
X7J
X7M
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
K9.
5PM
ID FETCH-LOGICAL-c577t-a8bcc22f57bc7aa6bd3f802ce2bd85d192934860f187e53405ee9c65437381b33
ISSN 0470-8105
IngestDate Thu Aug 21 13:57:10 EDT 2025
Mon Jun 30 07:54:33 EDT 2025
Thu Jan 02 23:08:55 EST 2025
Tue Jul 01 00:55:01 EDT 2025
Thu Apr 24 23:08:09 EDT 2025
Wed Sep 03 06:28:48 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords long-term outcome
epidemiology
treatment
chronic subdural hematoma
recurrence rate
Language English
License https://creativecommons.org/licenses/by-nc-nd/4.0
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c577t-a8bcc22f57bc7aa6bd3f802ce2bd85d192934860f187e53405ee9c65437381b33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
OpenAccessLink http://dx.doi.org/10.2176/nmc.ra.2016-0337
PMID 28652561
PQID 2015039727
PQPubID 2048494
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5566699
proquest_journals_2015039727
pubmed_primary_28652561
crossref_citationtrail_10_2176_nmc_ra_2016_0337
crossref_primary_10_2176_nmc_ra_2016_0337
jstage_primary_article_nmc_57_8_57_ra_2016_0337_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-00-00
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – year: 2017
  text: 2017-00-00
PublicationDecade 2010
PublicationPlace Japan
PublicationPlace_xml – name: Japan
– name: Tokyo
PublicationTitle Neurologia medico-chirurgica
PublicationTitleAlternate Neurol. Med. Chir.(Tokyo)
PublicationYear 2017
Publisher The Japan Neurosurgical Society
Japan Science and Technology Agency
Publisher_xml – name: The Japan Neurosurgical Society
– name: Japan Science and Technology Agency
References 29) Tsai TH, Lieu AS, Hwang SL, Huang TY, Hwang YF: A comparative study of the patients with bilateral or unilateral chronic subdural hematoma: precipitating factors and postoperative outcomes. J Trauma 68: 571–575, 2010
61) Tempaku A, Yamauchi S, Ikeda H, et al.: Usefulness of interventional embolization of the middle meningeal artery for recurrent chronic subdural hematoma: Five cases and a review of the literature. Interv Neuroradiol 21: 366–371, 2015
44) Tahsim-Oglou Y, Beseoglu K, Hänggi D, Stummer W, Steiger HJ: Factors predicting recurrence of chronic subdural haematoma: the influence of intraoperative irrigation and low-molecular-weight heparin thromboprophylaxis. Acta Neurochir (Wien) 154: 1063–1068 2012
59) Mandai S, Sakurai M, Matsumoto Y: Middle meningeal artery embolization for refractory chronic subdural hematoma. Case report. J Neurosurg 93: 686–688, 2000
58) Mobbs R, Khong P: Endoscopic-assisted evacuation of subdural collections. J Clin Neurosci 16: 701–704, 2009
69) Stippler M, Ramirez P, Berti A, Macindoe C, Villalobos N, Murray-Krezan C: Chronic subdural hematoma patients aged 90 years and older. Neurol Res 35: 243–246, 2013
70) Balser D, Farooq S, Mehmood T, Reyes M, Samadani U: Actual and projected incidence rates for chronic subdural hematomas in United States Veterans Administration and civilian populations. J Neurosurg 123: 1209–1215, 2015
26) Cook WL, Tomlinson G, Donaldson M, et al.: Falls and fall-related injuries in older dialysis patients. Clin J Am Soc Nephrol 1: 1197–1204, 2006
14) Májovský M, Masopust V, Netuka D, Beneš V: Flexible endoscope-assisted evacuation of chronic subdural hematomas. Acta Neurochir (Wien) 158: 1987–1992, 2016
22) Ducruet AF, Grobelny BT, Zacharia BE, et al.: The surgical management of chronic subdural hematoma. Neurosurg Rev 35: 155–169, 2012
67) Ro HW, Park SK, Jang DK, Yoon WS, Jang KS, Han YM: Preoperative predictive factors for surgical and functional outcomes in chronic subdural hematoma. Acta Neurochir (Wien) 158: 135–139, 2016
18) Miranda LB, Braxton E, Hobbs J, Quigley MR: Chronic subdural hematoma in the elderly: not a benign disease. J Neurosurg 114: 72–76, 2011
48) Rohde V, Graf G, Hassler W: Complications of burr-hole craniostomy and closed-system drainage for chronic subdural hematomas: a retrospective analysis of 376 patients. Neurosurg Rev 25: 89–94, 2002
64) Kawamata T, Takeshita M, Kubo O, Izawa M, Kagawa M, Takakura K: Management of intracranial hemorrhage associated with anticoagulant therapy. Surg Neurol 44: 438–443, 1995
39) Almenawer SA, Farrokhyar F, Hong C, et al.: Chronic subdural hematoma management: a systematic review and meta-analysis of 34,829 patients. Ann Surg 259: 449–457, 2014
36) Muramatsu M, Yoshikawa T, Hanabusa K: [Effectiveness of kampo medicine gorei-san-ryo for chronic subdural hematoma in very elderly patients]. No Shinkei Geka 33: 965–969, 2005 (Japanese
15) Leroy HA, Aboukaïs R, Reyns N, et al.: Predictors of functional outcomes and recurrence of chronic subdural hematomas. J Clin Neurosci 22: 1895–1900, 2015
7) Toi H, Kinoshita K, Hirai S, et al.: Present epidemiology of chronic subdural hematoma in Japan: analysis of 63,358 cases recorded in a national administrative database. J Neurosurg 2017
1) Foelholm R, Waltimo O: Epidemiology of chronic subdural haematoma. Acta Neurochir (Wien) 32: 247–250, 1975
60) Takizawa K, Sorimachi T, Ishizaka H, et al.: Enlargement of the middle meningeal artery on MR angiography in chronic subdural hematoma. J Neurosurg 124: 1679–1683, 2016
24) Leonard A, Shapiro FL: Subdural hematoma in regularly hemodialyzed patients. Ann Intern Med 82: 650–658, 1975
16) Santarius T, Kirkpatrick PJ, Ganesan D, et al.: Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial. Lancet 26: 1067–1073, 2009
53) Torihashi K, Sadamasa N, Yoshida K, Narumi O, Chin M, Yamagata S: Independent predictors for recurrence of chronic subdural hematoma: a review of 343 consecutive surgical cases. Neurosurgery 63: 1125–1129, 2008
57) Wakabayashi Y, Yamashita M, Asano T, et al.: [Effect of Gorei-san with tranexamic acid for preventing recurrence of chronic subdural hematoma]. No Shinkei Geka 40: 967–971, 2012 (Japanese
40) Weigel R, Schmiedek P, Krauss JK: Outcome of contemporary surgery for chronic subdural haematoma: evidence based review. J Neurol Neurosurg Psychiatr 74: 937–943, 2003
11) De Bonis P, Trevisi G, de Waure C, et al.: Antiplatelet/anticoagulant agents and chronic subdural hematoma in the elderly. PLoS One 8: e68732, 2013
41) Santarius T, Lawton R, Kirkpatrick PJ, Hutchinson PJ: The management of primary chronic subdural haematoma: a questionnaire survey of practice in the United Kingdom and the Republic of Ireland. Br J Neurosurg 22: 529–534, 2008
50) Mori K, Maeda M: Surgical treatment of chronic subdural hematoma in 500 consecutive cases: clinical characteristics, surgical outcome, complications, and recurrence rate. Neurol Med Chir (Tokyo) 41: 371–381, 2001
52) Goto H, Ishikawa O, Nomura M, Tanaka K, Nomura S, Maeda K: Magnetic resonance imaging findings predict the recurrence of chronic subdural hematoma. Neurol Med Chir (Tokyo) 55: 173–178, 2015
21) Shapey J, Glancz LJ, Brennan PM: Chronic Subdural Haematoma in the Elderly: Is It Time for a New Paradigm in Management? Curr Geriatr Rep 5: 71–77, 2016
42) Liu W, Bakker NA, Groen RJ: Chronic subdural hematoma: a systematic review and meta-analysis of surgical procedures. J Neurosurg 121: 665–673, 2014
37) Thotakura AK, Marabathina NR: Nonsurgical treatment of chronic subdural hematoma with steroids. World Neurosurg 84: 1968–1972, 2015
25) Sood P, Sinson GP, Cohen EP: Subdural hematomas in chronic dialysis patients: significant and increasing. Clin J Am Soc Nephrol 2: 956–959, 2007
43) Lee J, Park JH: Clinical Characteristics of Bilateral versus Unilateral Chronic Subdural Hematoma. Korean J Neurotrauma 10: 49–54, 2014
49) Abe Y, Maruyama K, Yokoya S, et al.: Outcomes of chronic subdural hematoma with preexisting comorbidities causing disturbed consciousness. J Neurosurg 27: 1–5, 2016
12) Borger V, Vatter H, Oszvald Á, Marquardt G, Seifert V, Güresir E: Chronic subdural haematoma in elderly patients: a retrospective analysis of 322 patients between the ages of 65–94 years. Acta Neurochir (Wien) 154: 1549–1554, 2012
19) Jones S, Kafetz K: A prospective study of chronic subdural haematomas in elderly patients. Age Ageing 28: 519–521, 1999
5) Hirakawa K, Hashizume K, Fuchinoue T, Takahashi H, Nomura K: Statistical analysis of chronic subdural hematoma in 309 adult cases. Neurol Med Chir (Tokyo) 12: 71–83, 1972
46) Ivamoto HS, Lemos HP, Atallah AN: Surgical treatments for chronic subdural hematomas: a comprehensive systematic review. World Neurosurg 86: 399–418, 2016
9) Statistics Bureau MoIAaC: Japan Annual Report of Population Estimates 2016
10) Ishibashi A, Yokokura Y, Miyagi J: Clinical analysis of nineteen patients with traumatic subdural hygromas. Kurume Med J 41: 81–85, 1994
2) Kudo H, Kuwamura K, Izawa I, Sawa H, Tamaki N: Chronic subdural hematoma in elderly people: present status on Awaji Island and epidemiological prospect. Neurol Med Chir (Tokyo) 32: 207–209, 1992
23) Power A, Hamady M, Singh S, Ashby D, Taube D, Duncan N: High but stable incidence of subdural haematoma in haemodialysis–a single-centre study. Nephrol Dial Transplant 25: 2272–2275, 2010
30) Huang YH, Yang KY, Lee TC, Liao CC: Bilateral chronic subdural hematoma: what is the clinical significance? Int J Surg 11: 544–548, 2013
47) Abouzari M, Rashidi A, Rezaii J, et al.: The role of postoperative patient posture in the recurrence of traumatic chronic subdural hematoma after burr-hole surgery. Neurosurgery 61: 794–797, 2007
62) Hashimoto T, Ohashi T, Watanabe D, et al.: Usefulness of embolization of the middle meningeal artery for refractory chronic subdural hematomas. Surg Neurol Int 4: 104, 2013
45) Ishibashi A, Yokokura Y, Adachi H: A comparative study of treatments for chronic subdural hematoma: burr hole drainage versus burr hole drainage with irrigation. Kurume Med J 58: 35–39, 2011
17) Kamenova M, Lutz K, Schaedelin S, Fandino J, Mariani L, Soleman J: Does Early Resumption of Low-Dose Aspirin After Evacuation of Chronic Subdural Hematoma With Burr-Hole Drainage Lead to Higher Recurrence Rates? Neurosurgery 79: 715–721, 2016
3) Karibe H, Kameyama M, Kawase M, Hirano T, Kawaguchi T, Tominaga T: [Epidemiology of chronic subdural hematomas]. No Shinkei Geka 39: 1149–1153, 2011 (Japanese
4) Asghar M, Adhiyaman V, Greenway MW, Bhowmick BK, Bates A: Chronic subdural haematoma in the elderly—a North Wales experience. J R Soc Med 95: 290–292, 2002
68) Dumont TM, Rughani AI, Goeckes T, Tranmer BI: Chronic subdural hematoma: a sentinel health event. World Neurosurg 80: 889–892, 2013
6) Fujioka S, Matsukado Y, Kaku M, Sakurama N, Nonaka N, Miura G: [CT analysis of 100 cases with chronic subdural hematoma with respect to clinical manifestation and the enlarging process of the hematoma (author’s transl)]. Neurol Med Chir (Tokyo) 21: 1153–1160, 1981
63) Adachi A, Higuchi Y, Fujikawa A, et al.: comparison of irrigation with artificial cerebrospinal fluid and normal saline in a cohort analysis. PLoS ONE 9: e103703, 2014
32) Lee KS, Shim JJ, Yoon SM, Doh JW, Yun IG, Bae HG: Acute-on-Chronic Subdural Hematoma: Not Uncommon Events. J Korean Neurosurg Soc 50: 512–516, 2011
28) Agawa Y, Mineharu Y, Tani S, Adachi H, Imamura H, Sakai N: Bilateral Chronic Subdural Hematoma is Associated with Rapid Progression and Poor Clinical Outcome. Neurol Med Chir (Tokyo) 56: 198–203, 2016 (Japanese
56) Berghauser Pont LM, Dirven CM, Dippel DW, Verweij BH, Dammers R: The role of corticosteroids in the management of chronic subdural hematoma: a systematic review. Eur J Neurol 2012: 1397–1403, 2012
51) Manickam A, Marshman LA, Johnston R: Long-term survival after chronic subdural haematoma. J Clin Neurosci 34: 100–104, 2016
66) Fukui S: [Evaluation of surgical treatment for chronic subdural hematoma
44
45
46
47
48
49
50
51
52
53
10
54
11
55
12
56
13
57
14
58
15
59
16
17
18
19
1
2
3
4
5
6
7
8
9
60
61
62
63
20
64
21
65
22
66
23
67
24
68
25
69
26
27
28
29
70
30
31
32
33
34
35
36
37
38
39
40
41
42
43
22476866 - Acta Neurochir (Wien). 2012 Jun;154(6):1063-7; discussion 1068
27460457 - J Clin Neurosci. 2016 Dec;34:100-104
4135996 - Neurol Med Chir (Tokyo). 1972;12(0):71-83
24032079 - Surg Neurol Int. 2013 Aug 19;4:104
26485412 - World Neurosurg. 2016 Feb;86:399-418
17986941 - Neurosurgery. 2007 Oct;61(4):794-7; discussion 797
23874740 - PLoS One. 2013 Jul 12;8(7):e68732
19663334 - No Shinkei Geka. 2009 Aug;37(8):765-70
6174887 - Neurol Med Chir (Tokyo). 1981 Nov;21(11):1153-60
28156246 - J Neurosurg. 2017 Feb 3;:1-7
22772400 - Acta Neurochir (Wien). 2012 Sep;154(9):1549-54
12042376 - J R Soc Med. 2002 Jun;95(6):290-2
24096761 - Ann Surg. 2014 Mar;259(3):449-57
8343296 - No To Shinkei. 1993 May;45(5):449-53
11014549 - J Neurosurg. 2000 Oct;93(4):686-8
26923835 - Neurol Med Chir (Tokyo). 2016;56(4):198-203
11954771 - Neurosurg Rev. 2002 Mar;25(1-2):89-94
21909694 - Neurosurg Rev. 2012 Apr;35(2):155-69; discussion 169
26407927 - World Neurosurg. 2016 Mar;87:529-30
22642223 - Eur J Neurol. 2012 Nov;19(11):1397-403
26015518 - Interv Neuroradiol. 2015 Jun;21(3):366-71
8629228 - Surg Neurol. 1995 Nov;44(5):438-42; discussion 443
25746312 - Neurol Med Chir (Tokyo). 2015 ;55(2):173-8
22722034 - World Neurosurg. 2013 Dec;80(6):889-92
12810784 - J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):937-43
20065879 - J Trauma. 2010 Mar;68(3):571-5
18686063 - Br J Neurosurg. 2008 Aug;22(4):529-34
24995782 - J Neurosurg. 2014 Sep;121(3):665-73
25794342 - J Neurosurg. 2015 Nov;123(5):1209-15
22128269 - No Shinkei Geka. 2011 Dec;39(12):1149-53
15823679 - Clin Neurol Neurosurg. 2005 Apr;107(3):223-9
26260114 - J Clin Neurosci. 2015 Dec;22(12):1895-900
21373348 - Int J Emerg Med. 2010 Nov 02;3(4):511-2
26602235 - Acta Neurochir (Wien). 2016 Jan;158(1):135-9
20106821 - Nephrol Dial Transplant. 2010 Jul;25(7):2272-5
19008766 - Neurosurgery. 2008 Dec;63(6):1125-9; discussion 1129
26344395 - Neurol Res. 2015 Nov;37(11):985-92
17702715 - Clin J Am Soc Nephrol. 2007 Sep;2(5):956-9
27231976 - J Neurosurg. 2017 Apr;126(4):1042-1046
22323938 - J Korean Neurosurg Soc. 2011 Dec;50(6):512-6
1094874 - Ann Intern Med. 1975 May;82(5):650-8
19261476 - J Clin Neurosci. 2009 May;16(5):701-4
24731576 - Clin Neurol Neurosurg. 2014 May;120:49-54
1378564 - Neurol Med Chir (Tokyo). 1992 Apr;32(4):207-9
16529021 - No Shinkei Geka. 2006 Mar;34(3):273-8
19782872 - Lancet. 2009 Sep 26;374(9695):1067-73
27081904 - J Neurosurg. 2017 Mar;126(3):755-759
27169033 - Korean J Neurotrauma. 2014 Oct;10(2):49-54
20868215 - J Neurosurg. 2011 Jan;114(1):72-6
26517775 - J Neurosurg. 2016 Jun;124(6):1679-83
7967442 - Kurume Med J. 1994;41(2):81-5
23641825 - J Neurosurg. 2013 Aug;119(2):332-7
22027196 - Kurume Med J. 2011;58(1):35-9
16223174 - No Shinkei Geka. 2005 Oct;33(10):965-9
27473394 - Acta Neurochir (Wien). 2016 Oct;158(10):1987-92
23485051 - Neurol Res. 2013 Apr;35(3):243-6
26361283 - J Neurosurg. 2016 Mar;124(3):750-9
27213133 - Curr Geriatr Rep. 2016;5:71-77
11561347 - Neurol Med Chir (Tokyo). 2001 Aug;41(8):371-81
1225014 - Acta Neurochir (Wien). 1975;32(3-4):247-50
17699348 - Clin J Am Soc Nephrol. 2006 Nov;1(6):1197-204
25089621 - PLoS One. 2014 Aug 04;9(8):e103703
26342776 - World Neurosurg. 2015 Dec;84(6):1968-72
23100384 - No Shinkei Geka. 2012 Nov;40(11):967-71
10604502 - Age Ageing. 1999 Oct;28(6):519-21
15148652 - Neurosurg Rev. 2004 Oct;27(4):263-6
16997707 - J Clin Neurosci. 2006 Oct;13(8):823-7
23707986 - Int J Surg. 2013;11(7):544-8
27538015 - Neurosurgery. 2016 Nov;79(5):715-721
References_xml – reference: 28) Agawa Y, Mineharu Y, Tani S, Adachi H, Imamura H, Sakai N: Bilateral Chronic Subdural Hematoma is Associated with Rapid Progression and Poor Clinical Outcome. Neurol Med Chir (Tokyo) 56: 198–203, 2016 (Japanese)
– reference: 14) Májovský M, Masopust V, Netuka D, Beneš V: Flexible endoscope-assisted evacuation of chronic subdural hematomas. Acta Neurochir (Wien) 158: 1987–1992, 2016
– reference: 32) Lee KS, Shim JJ, Yoon SM, Doh JW, Yun IG, Bae HG: Acute-on-Chronic Subdural Hematoma: Not Uncommon Events. J Korean Neurosurg Soc 50: 512–516, 2011
– reference: 36) Muramatsu M, Yoshikawa T, Hanabusa K: [Effectiveness of kampo medicine gorei-san-ryo for chronic subdural hematoma in very elderly patients]. No Shinkei Geka 33: 965–969, 2005 (Japanese)
– reference: 38) Shofty B, Grossman R: Treatment options for chronic subdural hematoma. World Neurosurg 87: 529–530, 2016
– reference: 52) Goto H, Ishikawa O, Nomura M, Tanaka K, Nomura S, Maeda K: Magnetic resonance imaging findings predict the recurrence of chronic subdural hematoma. Neurol Med Chir (Tokyo) 55: 173–178, 2015
– reference: 7) Toi H, Kinoshita K, Hirai S, et al.: Present epidemiology of chronic subdural hematoma in Japan: analysis of 63,358 cases recorded in a national administrative database. J Neurosurg 2017
– reference: 64) Kawamata T, Takeshita M, Kubo O, Izawa M, Kagawa M, Takakura K: Management of intracranial hemorrhage associated with anticoagulant therapy. Surg Neurol 44: 438–443, 1995
– reference: 1) Foelholm R, Waltimo O: Epidemiology of chronic subdural haematoma. Acta Neurochir (Wien) 32: 247–250, 1975
– reference: 19) Jones S, Kafetz K: A prospective study of chronic subdural haematomas in elderly patients. Age Ageing 28: 519–521, 1999
– reference: 27) Ooba S, Shiomi N, Shigemori M: [Clinical features and surgical results of chronic subdural hematoma in the extremely aged patients]. No Shinkei Geka 34: 273–278, 2006 (Japanese)
– reference: 21) Shapey J, Glancz LJ, Brennan PM: Chronic Subdural Haematoma in the Elderly: Is It Time for a New Paradigm in Management? Curr Geriatr Rep 5: 71–77, 2016
– reference: 57) Wakabayashi Y, Yamashita M, Asano T, et al.: [Effect of Gorei-san with tranexamic acid for preventing recurrence of chronic subdural hematoma]. No Shinkei Geka 40: 967–971, 2012 (Japanese)
– reference: 60) Takizawa K, Sorimachi T, Ishizaka H, et al.: Enlargement of the middle meningeal artery on MR angiography in chronic subdural hematoma. J Neurosurg 124: 1679–1683, 2016
– reference: 24) Leonard A, Shapiro FL: Subdural hematoma in regularly hemodialyzed patients. Ann Intern Med 82: 650–658, 1975
– reference: 8) Baechli H, Nordmann A, Bucher HC, Gratzl O: Demographics and prevalent risk factors of chronic subdural haematoma: results of a large single-center cohort study. Neurosurg Rev 27: 263–266, 2004
– reference: 47) Abouzari M, Rashidi A, Rezaii J, et al.: The role of postoperative patient posture in the recurrence of traumatic chronic subdural hematoma after burr-hole surgery. Neurosurgery 61: 794–797, 2007
– reference: 17) Kamenova M, Lutz K, Schaedelin S, Fandino J, Mariani L, Soleman J: Does Early Resumption of Low-Dose Aspirin After Evacuation of Chronic Subdural Hematoma With Burr-Hole Drainage Lead to Higher Recurrence Rates? Neurosurgery 79: 715–721, 2016
– reference: 4) Asghar M, Adhiyaman V, Greenway MW, Bhowmick BK, Bates A: Chronic subdural haematoma in the elderly—a North Wales experience. J R Soc Med 95: 290–292, 2002
– reference: 61) Tempaku A, Yamauchi S, Ikeda H, et al.: Usefulness of interventional embolization of the middle meningeal artery for recurrent chronic subdural hematoma: Five cases and a review of the literature. Interv Neuroradiol 21: 366–371, 2015
– reference: 3) Karibe H, Kameyama M, Kawase M, Hirano T, Kawaguchi T, Tominaga T: [Epidemiology of chronic subdural hematomas]. No Shinkei Geka 39: 1149–1153, 2011 (Japanese)
– reference: 48) Rohde V, Graf G, Hassler W: Complications of burr-hole craniostomy and closed-system drainage for chronic subdural hematomas: a retrospective analysis of 376 patients. Neurosurg Rev 25: 89–94, 2002
– reference: 54) Fujitani S, Ishikawa O, Miura K, Takeda Y, Goto H, Maeda K: Factors predicting contralateral hematoma growth after unilateral drainage of bilateral chronic subdural hematoma. J Neurosurg 126: 755–759, 2017
– reference: 5) Hirakawa K, Hashizume K, Fuchinoue T, Takahashi H, Nomura K: Statistical analysis of chronic subdural hematoma in 309 adult cases. Neurol Med Chir (Tokyo) 12: 71–83, 1972
– reference: 55) Wada M, Yamakami I, Higuchi Y, et al.: Influence of antiplatelet therapy on postoperative recurrence of chronic subdural hematoma: a multicenter retrospective study in 719 patients. Clin Neurol Neurosurg 120: 49–54, 2014
– reference: 25) Sood P, Sinson GP, Cohen EP: Subdural hematomas in chronic dialysis patients: significant and increasing. Clin J Am Soc Nephrol 2: 956–959, 2007
– reference: 69) Stippler M, Ramirez P, Berti A, Macindoe C, Villalobos N, Murray-Krezan C: Chronic subdural hematoma patients aged 90 years and older. Neurol Res 35: 243–246, 2013
– reference: 2) Kudo H, Kuwamura K, Izawa I, Sawa H, Tamaki N: Chronic subdural hematoma in elderly people: present status on Awaji Island and epidemiological prospect. Neurol Med Chir (Tokyo) 32: 207–209, 1992
– reference: 20) Gelabert-González M, Iglesias-Pais M, García-Allut A, Martínez-Rumbo R: Chronic subdural haematoma: surgical treatment and outcome in 1000 cases. Clin Neurol Neurosurg 107: 223–229, 2005
– reference: 67) Ro HW, Park SK, Jang DK, Yoon WS, Jang KS, Han YM: Preoperative predictive factors for surgical and functional outcomes in chronic subdural hematoma. Acta Neurochir (Wien) 158: 135–139, 2016
– reference: 15) Leroy HA, Aboukaïs R, Reyns N, et al.: Predictors of functional outcomes and recurrence of chronic subdural hematomas. J Clin Neurosci 22: 1895–1900, 2015
– reference: 51) Manickam A, Marshman LA, Johnston R: Long-term survival after chronic subdural haematoma. J Clin Neurosci 34: 100–104, 2016
– reference: 9) Statistics Bureau MoIAaC: Japan Annual Report of Population Estimates 2016
– reference: 56) Berghauser Pont LM, Dirven CM, Dippel DW, Verweij BH, Dammers R: The role of corticosteroids in the management of chronic subdural hematoma: a systematic review. Eur J Neurol 2012: 1397–1403, 2012
– reference: 6) Fujioka S, Matsukado Y, Kaku M, Sakurama N, Nonaka N, Miura G: [CT analysis of 100 cases with chronic subdural hematoma with respect to clinical manifestation and the enlarging process of the hematoma (author’s transl)]. Neurol Med Chir (Tokyo) 21: 1153–1160, 1981
– reference: 66) Fukui S: [Evaluation of surgical treatment for chronic subdural hematoma in extremely aged (over 80 years old) patients]. No To Shinkei 45: 449–453, 1993 (Japanese)
– reference: 63) Adachi A, Higuchi Y, Fujikawa A, et al.: comparison of irrigation with artificial cerebrospinal fluid and normal saline in a cohort analysis. PLoS ONE 9: e103703, 2014
– reference: 16) Santarius T, Kirkpatrick PJ, Ganesan D, et al.: Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial. Lancet 26: 1067–1073, 2009
– reference: 33) Kloss BT, Lagace RE: Acute-on-chronic subdural hematoma. Int J Emerg Med 3: 511–512, 2010
– reference: 37) Thotakura AK, Marabathina NR: Nonsurgical treatment of chronic subdural hematoma with steroids. World Neurosurg 84: 1968–1972, 2015
– reference: 39) Almenawer SA, Farrokhyar F, Hong C, et al.: Chronic subdural hematoma management: a systematic review and meta-analysis of 34,829 patients. Ann Surg 259: 449–457, 2014
– reference: 58) Mobbs R, Khong P: Endoscopic-assisted evacuation of subdural collections. J Clin Neurosci 16: 701–704, 2009
– reference: 53) Torihashi K, Sadamasa N, Yoshida K, Narumi O, Chin M, Yamagata S: Independent predictors for recurrence of chronic subdural hematoma: a review of 343 consecutive surgical cases. Neurosurgery 63: 1125–1129, 2008
– reference: 46) Ivamoto HS, Lemos HP, Atallah AN: Surgical treatments for chronic subdural hematomas: a comprehensive systematic review. World Neurosurg 86: 399–418, 2016
– reference: 62) Hashimoto T, Ohashi T, Watanabe D, et al.: Usefulness of embolization of the middle meningeal artery for refractory chronic subdural hematomas. Surg Neurol Int 4: 104, 2013
– reference: 42) Liu W, Bakker NA, Groen RJ: Chronic subdural hematoma: a systematic review and meta-analysis of surgical procedures. J Neurosurg 121: 665–673, 2014
– reference: 45) Ishibashi A, Yokokura Y, Adachi H: A comparative study of treatments for chronic subdural hematoma: burr hole drainage versus burr hole drainage with irrigation. Kurume Med J 58: 35–39, 2011
– reference: 31) Honda Y, Sorimachi T, Momose H, Takizawa K, Inokuchi S, Matsumae M: Chronic subdural haematoma associated with disturbance of consciousness: significance of acute-on-chronic subdural haematoma. Neurol Res 37: 985–992, 2015
– reference: 44) Tahsim-Oglou Y, Beseoglu K, Hänggi D, Stummer W, Steiger HJ: Factors predicting recurrence of chronic subdural haematoma: the influence of intraoperative irrigation and low-molecular-weight heparin thromboprophylaxis. Acta Neurochir (Wien) 154: 1063–1068 2012
– reference: 70) Balser D, Farooq S, Mehmood T, Reyes M, Samadani U: Actual and projected incidence rates for chronic subdural hematomas in United States Veterans Administration and civilian populations. J Neurosurg 123: 1209–1215, 2015
– reference: 23) Power A, Hamady M, Singh S, Ashby D, Taube D, Duncan N: High but stable incidence of subdural haematoma in haemodialysis–a single-centre study. Nephrol Dial Transplant 25: 2272–2275, 2010
– reference: 65) Guha D, Coyne S, Macdonald RL: Timing of the resumption of antithrombotic agents following surgical evacuation of chronic subdural hematomas: a retrospective cohort study. J Neurosurg 124: 750–759, 2016
– reference: 43) Lee J, Park JH: Clinical Characteristics of Bilateral versus Unilateral Chronic Subdural Hematoma. Korean J Neurotrauma 10: 49–54, 2014
– reference: 30) Huang YH, Yang KY, Lee TC, Liao CC: Bilateral chronic subdural hematoma: what is the clinical significance? Int J Surg 11: 544–548, 2013
– reference: 34) Kageyama H, Toyooka T, Tsuzuki N, Oka K: Nonsurgical treatment of chronic subdural hematoma with tranexamic acid. J Neurosurg 119: 332–337, 2013 (Japanese)
– reference: 49) Abe Y, Maruyama K, Yokoya S, et al.: Outcomes of chronic subdural hematoma with preexisting comorbidities causing disturbed consciousness. J Neurosurg 27: 1–5, 2016
– reference: 11) De Bonis P, Trevisi G, de Waure C, et al.: Antiplatelet/anticoagulant agents and chronic subdural hematoma in the elderly. PLoS One 8: e68732, 2013
– reference: 41) Santarius T, Lawton R, Kirkpatrick PJ, Hutchinson PJ: The management of primary chronic subdural haematoma: a questionnaire survey of practice in the United Kingdom and the Republic of Ireland. Br J Neurosurg 22: 529–534, 2008
– reference: 35) Miyagami M, Kagawa Y: [Effectiveness of Kampo medicine Gorei-San for chronic subdural hematoma]. No Shinkei Geka 37: 765–770, 2009 (Japanese)
– reference: 13) Rust T, Kiemer N, Erasmus A: Chronic subdural haematomas and anticoagulation or anti-thrombotic therapy. J Clin Neurosci 13: 823–827, 2006
– reference: 26) Cook WL, Tomlinson G, Donaldson M, et al.: Falls and fall-related injuries in older dialysis patients. Clin J Am Soc Nephrol 1: 1197–1204, 2006
– reference: 50) Mori K, Maeda M: Surgical treatment of chronic subdural hematoma in 500 consecutive cases: clinical characteristics, surgical outcome, complications, and recurrence rate. Neurol Med Chir (Tokyo) 41: 371–381, 2001
– reference: 18) Miranda LB, Braxton E, Hobbs J, Quigley MR: Chronic subdural hematoma in the elderly: not a benign disease. J Neurosurg 114: 72–76, 2011
– reference: 59) Mandai S, Sakurai M, Matsumoto Y: Middle meningeal artery embolization for refractory chronic subdural hematoma. Case report. J Neurosurg 93: 686–688, 2000
– reference: 68) Dumont TM, Rughani AI, Goeckes T, Tranmer BI: Chronic subdural hematoma: a sentinel health event. World Neurosurg 80: 889–892, 2013
– reference: 40) Weigel R, Schmiedek P, Krauss JK: Outcome of contemporary surgery for chronic subdural haematoma: evidence based review. J Neurol Neurosurg Psychiatr 74: 937–943, 2003
– reference: 22) Ducruet AF, Grobelny BT, Zacharia BE, et al.: The surgical management of chronic subdural hematoma. Neurosurg Rev 35: 155–169, 2012
– reference: 29) Tsai TH, Lieu AS, Hwang SL, Huang TY, Hwang YF: A comparative study of the patients with bilateral or unilateral chronic subdural hematoma: precipitating factors and postoperative outcomes. J Trauma 68: 571–575, 2010
– reference: 10) Ishibashi A, Yokokura Y, Miyagi J: Clinical analysis of nineteen patients with traumatic subdural hygromas. Kurume Med J 41: 81–85, 1994
– reference: 12) Borger V, Vatter H, Oszvald Á, Marquardt G, Seifert V, Güresir E: Chronic subdural haematoma in elderly patients: a retrospective analysis of 322 patients between the ages of 65–94 years. Acta Neurochir (Wien) 154: 1549–1554, 2012
– ident: 58
  doi: 10.1016/j.jocn.2008.06.023
– ident: 14
  doi: 10.1007/s00701-016-2902-5
– ident: 54
  doi: 10.3171/2016.1.JNS152655
– ident: 39
– ident: 52
  doi: 10.2176/nmc.oa.2013-0390
– ident: 35
– ident: 17
  doi: 10.1227/NEU.0000000000001393
– ident: 16
– ident: 44
  doi: 10.1007/s00701-012-1334-0
– ident: 46
  doi: 10.1016/j.wneu.2015.10.025
– ident: 28
  doi: 10.2176/nmc.oa.2015-0256
– ident: 55
– ident: 10
  doi: 10.2739/kurumemedj.41.81
– ident: 47
  doi: 10.1227/01.NEU.0000298908.94129.67
– ident: 9
– ident: 49
– ident: 2
  doi: 10.2176/nmc.32.207
– ident: 5
  doi: 10.2176/nmc.12.71
– ident: 34
  doi: 10.3171/2013.3.JNS122162
– ident: 50
  doi: 10.2176/nmc.41.371
– ident: 8
  doi: 10.1007/s10143-004-0337-6
– ident: 4
  doi: 10.1258/jrsm.95.6.290
– ident: 69
  doi: 10.1179/1743132813Y.0000000163
– ident: 15
  doi: 10.1016/j.jocn.2015.03.064
– ident: 7
  doi: 10.3171/2016.9.JNS16623
– ident: 21
  doi: 10.1007/s13670-016-0166-9
– ident: 67
  doi: 10.1007/s00701-015-2625-z
– ident: 25
  doi: 10.2215/CJN.03781106
– ident: 61
– ident: 37
  doi: 10.1016/j.wneu.2015.08.044
– ident: 59
  doi: 10.3171/jns.2000.93.4.0686
– ident: 29
  doi: 10.1097/TA.0b013e3181a5f31c
– ident: 40
  doi: 10.1136/jnnp.74.7.937
– ident: 27
– ident: 22
  doi: 10.1007/s10143-011-0349-y
– ident: 26
  doi: 10.2215/CJN.01650506
– ident: 12
  doi: 10.1007/s00701-012-1434-x
– ident: 66
– ident: 19
  doi: 10.1093/ageing/28.6.519
– ident: 56
  doi: 10.1111/j.1468-1331.2012.03768.x
– ident: 60
  doi: 10.3171/2015.5.JNS1567
– ident: 62
  doi: 10.4103/2152-7806.116679
– ident: 63
  doi: 10.1371/journal.pone.0103703
– ident: 30
  doi: 10.1016/j.ijsu.2013.05.007
– ident: 68
  doi: 10.1016/j.wneu.2012.06.026
– ident: 6
  doi: 10.2176/nmc.21.1153
– ident: 57
– ident: 31
  doi: 10.1179/1743132815Y.0000000083
– ident: 65
  doi: 10.3171/2015.2.JNS141889
– ident: 24
  doi: 10.7326/0003-4819-82-5-650
– ident: 3
– ident: 41
  doi: 10.1080/02688690802195381
– ident: 51
  doi: 10.1016/j.jocn.2016.05.026
– ident: 32
  doi: 10.3340/jkns.2011.50.6.512
– ident: 42
  doi: 10.3171/2014.5.JNS132715
– ident: 36
– ident: 11
  doi: 10.1371/journal.pone.0068732
– ident: 43
  doi: 10.13004/kjnt.2014.10.2.49
– ident: 45
  doi: 10.2739/kurumemedj.58.35
– ident: 18
  doi: 10.3171/2010.8.JNS10298
– ident: 33
  doi: 10.1007/s12245-010-0230-8
– ident: 13
  doi: 10.1016/j.jocn.2004.12.013
– ident: 70
  doi: 10.3171/2014.9.JNS141550
– ident: 38
  doi: 10.1016/j.wneu.2015.09.035
– ident: 53
  doi: 10.1227/01.NEU.0000335782.60059.17
– ident: 23
  doi: 10.1093/ndt/gfq013
– ident: 48
  doi: 10.1007/s101430100182
– ident: 20
  doi: 10.1016/j.clineuro.2004.09.015
– ident: 1
  doi: 10.1007/BF01405457
– ident: 64
  doi: 10.1016/0090-3019(95)00249-9
– reference: 22027196 - Kurume Med J. 2011;58(1):35-9
– reference: 27231976 - J Neurosurg. 2017 Apr;126(4):1042-1046
– reference: 27538015 - Neurosurgery. 2016 Nov;79(5):715-721
– reference: 12810784 - J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):937-43
– reference: 23874740 - PLoS One. 2013 Jul 12;8(7):e68732
– reference: 23707986 - Int J Surg. 2013;11(7):544-8
– reference: 23641825 - J Neurosurg. 2013 Aug;119(2):332-7
– reference: 25089621 - PLoS One. 2014 Aug 04;9(8):e103703
– reference: 17699348 - Clin J Am Soc Nephrol. 2006 Nov;1(6):1197-204
– reference: 26407927 - World Neurosurg. 2016 Mar;87:529-30
– reference: 1225014 - Acta Neurochir (Wien). 1975;32(3-4):247-50
– reference: 27460457 - J Clin Neurosci. 2016 Dec;34:100-104
– reference: 26361283 - J Neurosurg. 2016 Mar;124(3):750-9
– reference: 1378564 - Neurol Med Chir (Tokyo). 1992 Apr;32(4):207-9
– reference: 26015518 - Interv Neuroradiol. 2015 Jun;21(3):366-71
– reference: 22722034 - World Neurosurg. 2013 Dec;80(6):889-92
– reference: 8343296 - No To Shinkei. 1993 May;45(5):449-53
– reference: 20065879 - J Trauma. 2010 Mar;68(3):571-5
– reference: 15823679 - Clin Neurol Neurosurg. 2005 Apr;107(3):223-9
– reference: 26344395 - Neurol Res. 2015 Nov;37(11):985-92
– reference: 26517775 - J Neurosurg. 2016 Jun;124(6):1679-83
– reference: 28156246 - J Neurosurg. 2017 Feb 3;:1-7
– reference: 23485051 - Neurol Res. 2013 Apr;35(3):243-6
– reference: 6174887 - Neurol Med Chir (Tokyo). 1981 Nov;21(11):1153-60
– reference: 15148652 - Neurosurg Rev. 2004 Oct;27(4):263-6
– reference: 16997707 - J Clin Neurosci. 2006 Oct;13(8):823-7
– reference: 17702715 - Clin J Am Soc Nephrol. 2007 Sep;2(5):956-9
– reference: 7967442 - Kurume Med J. 1994;41(2):81-5
– reference: 26602235 - Acta Neurochir (Wien). 2016 Jan;158(1):135-9
– reference: 11014549 - J Neurosurg. 2000 Oct;93(4):686-8
– reference: 8629228 - Surg Neurol. 1995 Nov;44(5):438-42; discussion 443
– reference: 19261476 - J Clin Neurosci. 2009 May;16(5):701-4
– reference: 16223174 - No Shinkei Geka. 2005 Oct;33(10):965-9
– reference: 16529021 - No Shinkei Geka. 2006 Mar;34(3):273-8
– reference: 26923835 - Neurol Med Chir (Tokyo). 2016;56(4):198-203
– reference: 26342776 - World Neurosurg. 2015 Dec;84(6):1968-72
– reference: 22772400 - Acta Neurochir (Wien). 2012 Sep;154(9):1549-54
– reference: 24731576 - Clin Neurol Neurosurg. 2014 May;120:49-54
– reference: 26260114 - J Clin Neurosci. 2015 Dec;22(12):1895-900
– reference: 18686063 - Br J Neurosurg. 2008 Aug;22(4):529-34
– reference: 23100384 - No Shinkei Geka. 2012 Nov;40(11):967-71
– reference: 20106821 - Nephrol Dial Transplant. 2010 Jul;25(7):2272-5
– reference: 24096761 - Ann Surg. 2014 Mar;259(3):449-57
– reference: 20868215 - J Neurosurg. 2011 Jan;114(1):72-6
– reference: 26485412 - World Neurosurg. 2016 Feb;86:399-418
– reference: 27213133 - Curr Geriatr Rep. 2016;5:71-77
– reference: 21909694 - Neurosurg Rev. 2012 Apr;35(2):155-69; discussion 169
– reference: 25746312 - Neurol Med Chir (Tokyo). 2015 ;55(2):173-8
– reference: 19663334 - No Shinkei Geka. 2009 Aug;37(8):765-70
– reference: 1094874 - Ann Intern Med. 1975 May;82(5):650-8
– reference: 22642223 - Eur J Neurol. 2012 Nov;19(11):1397-403
– reference: 11561347 - Neurol Med Chir (Tokyo). 2001 Aug;41(8):371-81
– reference: 17986941 - Neurosurgery. 2007 Oct;61(4):794-7; discussion 797
– reference: 11954771 - Neurosurg Rev. 2002 Mar;25(1-2):89-94
– reference: 19008766 - Neurosurgery. 2008 Dec;63(6):1125-9; discussion 1129
– reference: 22476866 - Acta Neurochir (Wien). 2012 Jun;154(6):1063-7; discussion 1068
– reference: 10604502 - Age Ageing. 1999 Oct;28(6):519-21
– reference: 24995782 - J Neurosurg. 2014 Sep;121(3):665-73
– reference: 27473394 - Acta Neurochir (Wien). 2016 Oct;158(10):1987-92
– reference: 12042376 - J R Soc Med. 2002 Jun;95(6):290-2
– reference: 21373348 - Int J Emerg Med. 2010 Nov 02;3(4):511-2
– reference: 19782872 - Lancet. 2009 Sep 26;374(9695):1067-73
– reference: 27169033 - Korean J Neurotrauma. 2014 Oct;10(2):49-54
– reference: 27081904 - J Neurosurg. 2017 Mar;126(3):755-759
– reference: 25794342 - J Neurosurg. 2015 Nov;123(5):1209-15
– reference: 4135996 - Neurol Med Chir (Tokyo). 1972;12(0):71-83
– reference: 22323938 - J Korean Neurosurg Soc. 2011 Dec;50(6):512-6
– reference: 24032079 - Surg Neurol Int. 2013 Aug 19;4:104
– reference: 22128269 - No Shinkei Geka. 2011 Dec;39(12):1149-53
SSID ssib002484387
ssj0037382
ssib002484385
Score 2.4327044
SecondaryResourceType review_article
Snippet As the world population becomes progressively older, the overall incidence of chronic subdural hematoma (CSDH) is increasing. Peak age of onset for CSDH has...
SourceID pubmedcentral
proquest
pubmed
crossref
jstage
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 402
SubjectTerms Age of Onset
Aged
Aged, 80 and over
Anesthesia
Anticoagulants
Benign
Blood
Brain
Brain Injuries, Traumatic - complications
Cerebral Hemorrhage - chemically induced
chronic subdural hematoma
Cognition Disorders - etiology
Cognitive ability
Consciousness Disorders - etiology
Craniotomy
Drainage
Dura mater
epidemiology
Female
Geriatrics
Hematologic Agents - adverse effects
Hematoma
Hematoma, Subdural, Chronic - complications
Hematoma, Subdural, Chronic - epidemiology
Hematoma, Subdural, Chronic - surgery
Hospital Mortality
Humans
Japan - epidemiology
long-term outcome
Male
Memory
Meninges
Patients
Population Dynamics
Recurrence
recurrence rate
Renal Dialysis - adverse effects
Review
Risk Factors
Surgery
treatment
Treatment Outcome
Urinary incontinence
Urinary Incontinence - etiology
Title Chronic Subdural Hematoma in Elderly Patients: Is This Disease Benign?
URI https://www.jstage.jst.go.jp/article/nmc/57/8/57_ra.2016-0337/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/28652561
https://www.proquest.com/docview/2015039727
https://pubmed.ncbi.nlm.nih.gov/PMC5566699
Volume 57
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Neurologia medico-chirurgica, 2017, Vol.57(8), pp.402-409
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfK4IEXBOKrMCY_8IJQtjiJ44SXaaChFrQO0Crtich23DZoS1HSPoy_nrvYCWkZiPFita5zbnzn893Z9zMhLw1XMyEj7qVRmnhR6Cee1Cz14kgYwxGBLMfQwMkkHk2jD-f8fDD42ju1tF6pff3j2ryS_-Eq1AFfMUv2BpztiEIFfAb-QgkchvKfeOyQbXH25w18xggRWJeXEqMYx3j_9sUVgvAXzWkJ8P3HNV7UWSPmJm7LvH5rymJebh3ua_A6UCVKu_O-9PSiqNbVvHesZzo5tZk-tQQTtHP_T8fNUlZUy6v1r-rR-MvR2IafV8t6UfQjDTal0qmiSPhewny7_2ysqgyjFNY3F69wupSLnswkPcUY-UFvjY0aSITf1De4RxhJKC_1foWYUCz2_NBiwmwiZW-tYN25QvBokEYGFLJKZkghQwq3yO0A3AhU3B8_992tJAoTvvW9c9gR9KnZhWrf3m5zYw8H2_9xw6y58w0s-7m5zmnZPnvbM2bO7pN7zguhR1akHpCBKR-SFiiZtuJEW3GiRUmdONFWnN7QcU1RmKgTJmqF6fARmb4_Pns38tw1G57mQqw8mSitg2DGhdJCyljl4Qz4qk2g8oTn4AKkIV5VNmOJMDwEC9-YVGNOMowPU2H4mOyUy9I8JdSkSs-YYjIGyzTnsRRMMJYCqVxBF-GQHLSjlGmHQY9XoVxkf-LckLzqnvhu8Vf-0vbQDnzX0s3MpiUXWYJF_4muAaY4gkYZkt2WY5mb5zW25j6Y7QF08MQyr-sA87rBaWBDIjbY2jVA9PbNX8pi0aC4c3Ck4jR9doMXfE7u4ry0EcBdsrOq1uYF2MQrtdfEkvYa8YZy8unkJ3k8tQ0
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chronic+Subdural+Hematoma+in+Elderly+Patients%3A+Is+This+Disease+Benign%3F&rft.jtitle=Neurologia+medico-chirurgica&rft.au=UNO%2C+Masaaki&rft.au=TOI%2C+Hiroyuki&rft.au=HIRAI%2C+Satoshi&rft.date=2017&rft.issn=0470-8105&rft.eissn=1349-8029&rft.volume=57&rft.issue=8&rft.spage=402&rft.epage=409&rft_id=info:doi/10.2176%2Fnmc.ra.2016-0337&rft.externalDBID=n%2Fa&rft.externalDocID=10_2176_nmc_ra_2016_0337
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0470-8105&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0470-8105&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0470-8105&client=summon